Search

Virtually all cervical cancer cases are caused by human papilloma viruses (HPV), mainly HPV-16 and HPV-18. Furthermore, HPVs may cause other types of cancer, such as squamous anal cancers and vulvar cancer. In men, HPVs are associated with genital lesions, anal cancer, penile cancer, and head and neck cancers. As such, this compilation focuses on recent findings in HPV epidemiology, prevention, and updates regarding prophylatic HPV vaccines. Bioinformatics tool are important in the analysis of molecular and biological data, which could provide novel insights on the development of treatment and prevention methods for disease control. Through bioinformatics, it is possible to analyze and simulate HPV molecular data through the use of universal databases and analysis tools, in order to better understand the virus genetics and infection cycle. In conclusion, Human Papillomaviruses (HPVs): Detection, Infection and Protection appraises HPV vaccines for the prophylaxis of HPV infection in healthy individuals. Vaccines used for earlier varieties are Gardasil (Merck, Kenilworth, NJ, U.S.A.) and Cervarix (GlaxoSmithKline, Brentford, U.K.).

Human papillomavirus (HPV) infection is one of the most frequently sexually transmitted diseases in the world. HPV infections are responsible for almost all cases of genital warts and are also responsible for multiple cancer in different regions of the body. Several studies on HPV diagnosis and vaccine development are in progress. Recently, two commercial vaccines such as Gardasil and Cervarix have been used to prevent HPV infections. Various drugs have also been tested in clinical trials for the treatment of HPV-related cancers. HPV infections: Diagnosis, Prevention, and Treatment provides a comprehensive overview of diagnosis, prevention and treatment in HPV-related infections. Chapters cover a large range of topics including HPV epidemiology, molecular biology, transmission, diagnosis, prevention, and treatment along with information about preclinical and clinical experiments. This book is intended as a comprehensive handbook for medical students and residents who require information about HPV and the treatment of HPV related diseases.

Human papillomavirus (HPV) infection transcends multiple fields of science and medicine. The management of HPV-related disease is demanding and often requires a persistent multimodal approach involving various medical disciplines. In this volume, experts present a comprehensive view of HPV research with an emphasis on clinical presentations, diagnosis, management and vaccine development. The state of the art in molecular biology is provided in addition to discussions on clinical morphology and the utility of dermatoscopy in identifying HPV disease. In a multidisciplinary approach to dermatological, plastic and reconstructive, gynecological, otolaryngological and colorectal management, different treatment strategies are highlighted. Finally, Dr. Neil Christensen discusses viral immunology, and the difficulties and successes in the development of an HPV vaccine. Bringing together basic science and clinical information on HPV, this book is an excellent resource and reference for all researchers and clinicians who encounter human papillomavirus-related disease.

Human papillomavirus (HPV) is one of the most common causes of sexually transmitted diseases worldwide, both in men and women. Human papillomavirus infections provides the scientific background needed to understand the natural history and pathogenesis of HPV infection and offers discussion of its clinical features, diagnosis, treatment and prevention. The book begins with chapters covering the epidemiology, virology, history and transmission of the infection, as well as its pathogenesis and clinical features. Following a discussion of the relationship between HPV and cancer, chapters in the second half of the book look at diagnosis, testing and treatment. The book concludes with detailed coverage of the prevention of HPV through worldwide vaccination programmes. - Covers all the important issues relating to both male and female HPV infection - Provides overview of the current knowledge about epidemiology, basic virology, pathogenesis and diagnosis methods - Explores the relationship between HPV and cancer

Human papillomaviruses (HPV) are a heterogeneous and still growing virus family. Topical research results on the replication cycle and carcinogenic mechanisms allow a better understanding of current prevention strategies. Written by leading experts, this volume of Monographs in Virology provides up-to-date information on the prevention of papillomavirus-induced cancers by prophylactic antiviral vaccines and early detection of precancerous lesions. A major section covers the tremendous clinical burden due to HPV infections: genital warts and laryngeal papillomas, the most notorious cervical cancer, but also further anogenital and tonsillar cancer, the incidence of which increased steeply during the last decades. Additionally, a section on prevention addresses the subject cytology - new concepts of biomarker development, detection of HPV DNA and RNA as well as their use in primary screening for early detection of precancerous lesions. Finally the book closes with a topical discussion of the most intriguing primary prevention of HPV infection by vaccination. As new perspectives for the prevention of HPV-related neoplasia raised great public interest, this book will be of value to clinicians and practitioners in gynecology, dermatology, urology and ENT, to pathologists, laboratory physicians, medical students, and public health authorities.

Despite the substantial efforts made to prevent the disease by early detection, cervical cancer remains a leading cause of mortality among women worldwide. The European Research Organization on Genital Infection and Neoplasia (EUROGIN) pursues a wide variety of educational and training activities, aiming to spread accurate and state-of-the-art information in the field of cervical cancer prevention. The latest outcome of these activities is presented in this book. Providing a concise update of the current knowledge on human papillomavirus (HPV) infections and their intimate link to cervical cancer, the book focuses on five interrelated topics: high- and low-risk HPV infections, methods for HPV detection and use of molecular markers, HPV testing in primary screening and patient management, morphological diagnosis and treatment, as well as prevention of cervical cancer by vaccines. Written by leading international experts, this publication is targeted at a multidisciplinary readership consisting of health care professionals from diverse specialties engaged in the management of HPV-associated diseases.

L'impact de l'infection à papillomavirus (HPV) est considérable. Plus d'une femme sur deux a été exposée aux HPV durant sa vie et 10% environ feront une infection chronique. Parmi elles, 20% développeront un cancer du col en l'absence ou par défaillance du dépistage. En France, l'infection à HPV à risque provoque 80 000 lésions précancéreuses, 3 400 cancers du col utérin et le décès de 1 000 femmes tous les ans. Le dépistage par frottis réalisé à un rythme régulier et selon des normes de qualité a entraîné une diminution significative de l'incidence et de la mortalité ces vingt dernières années. Cependant, malgré ce succès considérable, la maladie réputée évitable n'a pas été éradiquée, le dépistage est un processus complexe qui ne profite qu'à une partie de la population alors que ceux qui en bénéficient endurent ses faiblesses. L'optimisation du dépistage et de la prise en charge est aujourd'hui rendue possible par l'utilisation de techniques innovantes dans lesquelles s'inscrivent le frottis en suspension liquide, le test HPV, et bientôt le génotypage viral et les marqueurs moléculaires garantissant une protection maximum. Parce que le cancer du col utérin est la conséquence de l'infection chronique à HPV on dispose déjà de l'extraordinaire chance de le prévenir par un vaccin prophylactique. Ce progrès aura un impact majeur sur nos pratiques alors qu'il arrive dans un environnement médico-sociologique peu préparé. Cet ouvrage résolument pratique et didactique dresse un état des lieux des connaissances et des perspectives sur l'infection à HPV et ses pathologies associées tout en décryptant les nouveaux enjeux et les pratiques à l'ère vaccinale.